FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

729411000001107: Adgyn Medro 5mg tablets (Strakan Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16849701000001115 Adgyn Medro 5mg tablets (Strakan Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
100623001000001111 Adgyn Medro 5mg tablets (Kyowa Kirin Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adgyn Medro 5mg tablets (Strakan Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Is a Product containing precisely medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has active ingredient Medroxyprogesterone acetate false Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Is a Adgyn Medro true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has specific active ingredient Medroxyprogesterone acetate true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Is pack of False Adgyn Medro 5mg tablets (Strakan Ltd) Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 28 tablet Is pack of False Adgyn Medro 5mg tablets (Strakan Ltd) Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 14 tablet Has AMP True Adgyn Medro 5mg tablets (Strakan Ltd) Inferred relationship Existential restriction modifier
Adgyn Medro 5mg tablets (Strakan Ltd) 28 tablet Has AMP True Adgyn Medro 5mg tablets (Strakan Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start